Parvovirus B19 DNA Detection (Qualitative) Test in UAE | 700 AED | DHA Licensed

Executive Summary & Core Metrics

Diagnostic Accuracy: 99.9% analytical sensitivity via ISO 9001:2015 certified laboratory (Certificate: INT/EGQ/2509DA/3139).
Logistics: Hospital extraction only – sample collection is conducted strictly within an accredited hospital facility; mobile home phlebotomy is disabled for safety. Secure medical courier for specimen transport.
Medical Guidance: Post‑result telephonic counselling to interpret clinical significance.
Insurance: Direct coverage verification via WhatsApp +971 54 548 8731.

Test Overview & Methodology

This qualitative real‑time PCR test directly detects parvovirus B19 DNA in respiratory secretions, confirming active viral shedding with near‑perfect specificity. The method targets conserved genomic regions, ensuring high sensitivity across circulating genotypes.

Feature	Our Test (DNA PCR)	Closest Alternative (IgM/IgG Serology)
Target	Viral DNA (active infection)	Host antibodies (past/exposure)
Method	Real‑Time PCR (qPCR) – Gold Standard	ELISA / CLIA
Turnaround	36–48 hours	24–48 hours
Sensitivity	>99.9% (Limit of Detection 50 IU/mL)	70–90% (window period dependent)
Price	700 AED	~350 AED

Physician Insight & Safety Protocols

“Active parvovirus B19 infection can have serious implications, particularly for pregnant patients and immunocompromised individuals. This DNA test provides definitive evidence of viral shedding, enabling timely clinical decisions. Always interpret results alongside a complete history and physical examination.”

— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID 9294403

Advisory & Safety Precautions

⚠️ Medication & Clinical Advisory

Do not discontinue any prescribed medication without prior consultation with your physician. A positive parvovirus B19 DNA result does not replace a full clinical evaluation; always seek immediate medical guidance.

Patient Safety Exclusion Criteria

Active bleeding disorder or anticoagulation therapy that contraindicates nasopharyngeal swabbing.
Minors under 12 years without written guardian consent as per Federal Law No. 2 of 2019.
Inability to provide an adequate respiratory secretion sample.

🚨 Emergency Red Flags – Seek Immediate Medical Care

Sudden high fever with severe joint pain or profound fatigue.
Signs of acute anemia: extreme pallor, shortness of breath, rapid heartbeat.
During pregnancy: marked decrease in fetal movements or new rash with anemia symptoms.

Patient FAQ & Clinical Guidance

1. What does a positive Parvovirus B19 DNA qualitative test mean?

A positive result indicates active parvovirus B19 infection with viral DNA detected in your respiratory sample, requiring immediate clinical correlation and possible isolation precautions.

2. How accurate is this test compared to traditional antibody tests?

Our real‑time PCR achieves >99.9% analytical sensitivity and specificity, far exceeding serology tests which may miss early infections or return false negatives during the serological window period.

3. Why is a respiratory sample collected instead of blood?

Parvovirus B19 DNA concentrates in respiratory secretions during acute infection, providing a non‑invasive sample with high viral yield, while blood‑based antibody tests detect only host response.

4. Can this test be performed during pregnancy?

Yes, with appropriate medical supervision. The nasopharyngeal swab is safe for all trimesters, but results must be discussed with an obstetrician immediately due to risk of fetal hydrops.

UAE Regulatory & Data Privacy Adherence

Health Data Protection: All test data is processed in full compliance with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL).
Healthcare ICT Governance: Secure electronic health records are maintained under Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
Medical Liability: Clinical testing and patient consent procedures adhere to Federal Decree‑Law No. 4 of 2016 on Medical Liability.
Accreditation: Laboratory operations are ISO 9001:2015 certified (Certificate: INT/EGQ/2509DA/3139).

Clinical & Logistical Metadata

Test Name	Parvovirus B19 DNA Detection (Qualitative)
Price (AED)	700
Turnaround Time	36 to 48 hours
Sample Type / Matrix	Respiratory secretion (nasopharyngeal swab) – Hospital Extraction Only. Sample collection is conducted strictly within an accredited hospital facility; mobile home phlebotomy is disabled for safety.
Methodology Used	Real‑Time PCR (qPCR)
ICD-10-CM Code	B08.3 (Erythema infectiosum), B97.6 (Parvovirus as cause of diseases classified elsewhere)
LOINC Code	25998-7 (Parvovirus B19 DNA [Presence] in Specimen by NAA with probe detection)
DHA Facility License & Laboratory Address	DHA License Number: 1143 DNA Labs UAE Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE